Compare Allbirds Inc (BIRD) vs CVS Health Corp (CVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allbirds Inc vs CVS Health Corp — how do they compare? Allbirds Inc trades at $2.96 (market cap $26.33M), while CVS Health Corp trades at $106.03 (market cap $135.12B). The key difference: CVS Health Corp is far larger — about 5131.8× Allbirds Inc's market cap, and CVS Health Corp pays a 2.51% dividend while Allbirds Inc pays none. Which is the better fit depends on your goals.
| BIRD | CVS | |
|---|---|---|
Market Cap | $26.33M | $135.12B |
Sector | Consumer Cyclical | Health |
52-Week High | $16.99 | $106.18 |
52-Week Low | $2.39 | $58.75 |
Enterprise Value | $45.20M | $201.66B |
Dividend Yield | — | 2.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BIRD (Smartbird) trades at $3.00, down 4.15% today, amid a complete pivot from footwear to AI infrastructure. The stock shows a bearish technical signal with flat support/resistance at $3.00, while oscillators like RSI indicate oversold conditions. Financially, revenue has declined from $298M in 2022 to $152M in 2025, with persistent net losses and negative cash flow. Recent news highlights the rebrand to Smartbird and new CEO appointment, driving volatility.
The outlook is highly speculative; the AI pivot offers growth potential but execution risks are severe given the company's unprofitable history and cash burn. Analyst consensus is cautious with 79% hold ratings. Investors face significant uncertainty around the new business model's viability and funding needs.
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Allbirds Inc
Allbirds Inc is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products. Its primary source of revenue is from sales of shoes and apparel products in its directly owned digital and physical retail channels.
Read more on BIRD →About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →
